TP53 and pancreatic neoplasm: We used the iKras* and iKras* p53* genetically engineered mouse models of pancreatic cancer that express oncogenic KrasG12D in the pancreas epithelium in an inducible and reversible manner (Collins et al, 2012a, 2012b).